Year archive

Ascletis Pharma Inc. — 2023 filings

All 178 regulatory filings released by Ascletis Pharma Inc. (1672) in 2023, sourced directly from the official regulator.

178 Filings

2023 Period

2023 filings (178)

Filing	Released	Lang
Next Day Disclosure Return Regulatory Filings	2023-12-22	English
Next Day Disclosure Return Regulatory Filings	2023-12-21	English
Next Day Disclosure Return Regulatory Filings	2023-12-20	English
Next Day Disclosure Return Regulatory Filings	2023-12-19	English
Next Day Disclosure Return Regulatory Filings	2023-12-18	English
Next Day Disclosure Return Regulatory Filings	2023-12-15	English
Next Day Disclosure Return Regulatory Filings	2023-12-14	English
Next Day Disclosure Return Regulatory Filings	2023-12-13	English
Next Day Disclosure Return Regulatory Filings	2023-12-12	English
Next Day Disclosure Return Regulatory Filings	2023-12-11	English
Next Day Disclosure Return Regulatory Filings	2023-12-08	English
Next Day Disclosure Return Regulatory Filings	2023-12-07	English
Next Day Disclosure Return Regulatory Filings	2023-12-06	English
Next Day Disclosure Return Regulatory Filings	2023-12-05	English
VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES INITIATION OF PHASE III CLINICAL TRIAL OF ASC40 (DENIFANSTAT) FOR TREATMENT OF ACNE Regulatory Filings	2023-12-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023 Regulatory Filings	2023-12-05	English
Next Day Disclosure Return Regulatory Filings	2023-12-04	English
Next Day Disclosure Return Regulatory Filings	2023-12-01	English
Monthly Return of Equity Issuer on movements in Securities for the month ended 30 November 2023 Regulatory Filings	2023-12-01	English
Next Day Disclosure Return Regulatory Filings	2023-11-30	English
Next Day Disclosure Return Regulatory Filings	2023-11-29	English
Next Day Disclosure Return Regulatory Filings	2023-11-28	English
Next Day Disclosure Return Regulatory Filings	2023-11-27	English
Next Day Disclosure Return Regulatory Filings	2023-11-24	English
Next Day Disclosure Return Regulatory Filings	2023-11-23	English
Next Day Disclosure Return Regulatory Filings	2023-11-22	English
Next Day Disclosure Return Regulatory Filings	2023-11-21	English
Next Day Disclosure Return Regulatory Filings	2023-11-20	English
Next Day Disclosure Return Regulatory Filings	2023-11-16	English
Next Day Disclosure Return Regulatory Filings	2023-11-15	English
Next Day Disclosure Return Regulatory Filings	2023-11-14	English
VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES POSTER PRESENTATIONS AT AASLD ANNUAL MEETING 2023 INCLUDING A LATE-BREAKING ABSTRACT OF INTERIM RESULTS FROM PHASE IIB EXPANSION COHORT OF ASC22 FOR FUNCTIO Regulatory Filings	2023-11-13	English
Next Day Disclosure Return Regulatory Filings	2023-11-10	English
Next Day Disclosure Return Regulatory Filings	2023-11-09	English
Next Day Disclosure Return Regulatory Filings	2023-11-08	English
Next Day Disclosure Return Regulatory Filings	2023-11-07	English
Next Day Disclosure Return Regulatory Filings	2023-11-06	English
VOLUNTARY ANNOUNCEMENT - GANNEX PUBLISHED PHASE I DATA OF ASC42, A NOVEL FARNESOID X RECEPTOR AGONIST ON THE JOURNAL DRUGS IN R&D Regulatory Filings	2023-11-06	English
Next Day Disclosure Return Regulatory Filings	2023-11-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023 Regulatory Filings	2023-11-03	English
Next Day Disclosure Return Regulatory Filings	2023-11-02	English
Monthly Return of Equity Issuer on movements in Securities for the month ended 31 October 2023 Regulatory Filings	2023-11-02	English
Next Day Disclosure Return Regulatory Filings	2023-11-01	English
Next Day Disclosure Return Regulatory Filings	2023-10-31	English
Next Day Disclosure Return Regulatory Filings	2023-10-30	English
Next Day Disclosure Return Regulatory Filings	2023-10-27	English
Next Day Disclosure Return Regulatory Filings	2023-10-26	English
Next Day Disclosure Return Regulatory Filings	2023-10-25	English
Next Day Disclosure Return Regulatory Filings	2023-10-24	English
Next Day Disclosure Return Regulatory Filings	2023-10-20	English
Next Day Disclosure Return Regulatory Filings	2023-10-19	English
Next Day Disclosure Return Regulatory Filings	2023-10-18	English
Next Day Disclosure Return Regulatory Filings	2023-10-17	English
Next Day Disclosure Return Regulatory Filings	2023-10-16	English
Next Day Disclosure Return Regulatory Filings	2023-10-12	English
Next Day Disclosure Return Regulatory Filings	2023-10-11	English
VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES POSTER PRESENTATION OF PHASE II STUDY TOPLINE RESULTS OF FASN INHIBITOR ASC40 FOR TREATMENT OF ACNE AT EADV CONGRESS 2023 Regulatory Filings	2023-10-11	English
Next Day Disclosure Return Regulatory Filings	2023-10-10	English
Next Day Disclosure Return Regulatory Filings	2023-10-09	English
Next Day Disclosure Return Regulatory Filings	2023-10-06	English
Next Day Disclosure Return Regulatory Filings	2023-10-05	English
Next Day Disclosure Return Regulatory Filings	2023-10-04	English
Next Day Disclosure Return Regulatory Filings	2023-10-03	English
Monthly Return of Equity Issuer on movements in Securities for the month ended 30 September 2023 Regulatory Filings	2023-10-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023 Regulatory Filings	2023-10-03	English
Next Day Disclosure Return Regulatory Filings	2023-09-29	English
VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES POSITIVE INTERIM DATA FROM THE PHASE IIB EXPANSION COHORT OF ASC22 (ENVAFOLIMAB) FOR CHRONIC HEPATITIS B FUNCTIONAL CURE Regulatory Filings	2023-09-29	English
Next Day Disclosure Return Regulatory Filings	2023-09-28	English
Next Day Disclosure Return Regulatory Filings	2023-09-27	English
Notification Letter with Request Form to Non-Registered Holders of Shares - Notice of Publication of Interim Report 2023 Regulatory Filings	2023-09-27	English
Interim Report 2023 Regulatory Filings	2023-09-27	English
Next Day Disclosure Return Regulatory Filings	2023-09-26	English
VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES COMPLETION OF ENROLLMENT OF 120 PATIENTS IN THE PHASE III CLINICAL TRIAL OF FASN INHIBITOR ASC40 COMBINED WITH BEVACIZUMAB FOR TREATMENT OF RECURRENT GLIOB Regulatory Filings	2023-09-26	English
Next Day Disclosure Return Regulatory Filings	2023-09-25	English
Next Day Disclosure Return Regulatory Filings	2023-09-21	English
Next Day Disclosure Return Regulatory Filings	2023-09-20	English
INTERIM REPORT 2023 Regulatory Filings	2023-09-20	English
Next Day Disclosure Return Regulatory Filings	2023-09-18	English
Next Day Disclosure Return Regulatory Filings	2023-09-15	English
Next Day Disclosure Return Regulatory Filings	2023-09-14	English
Next Day Disclosure Return Regulatory Filings	2023-09-13	English
Next Day Disclosure Return Regulatory Filings	2023-09-12	English
Next Day Disclosure Return Regulatory Filings	2023-09-11	English
Next Day Disclosure Return Regulatory Filings	2023-09-07	English
Next Day Disclosure Return Regulatory Filings	2023-09-06	English
Next Day Disclosure Return Regulatory Filings	2023-09-05	English
Monthly Return of Equity Issuer on movements in Securities for the month ended 31 August 2023 Regulatory Filings	2023-09-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023 Regulatory Filings	2023-09-05	English
Next Day Disclosure Return Regulatory Filings	2023-09-04	English
Next Day Disclosure Return Regulatory Filings	2023-08-31	English
Next Day Disclosure Return Regulatory Filings	2023-08-30	English
Next Day Disclosure Return Regulatory Filings	2023-08-29	English
Next Day Disclosure Return Regulatory Filings	2023-08-28	English
ANNOUNCEMENT OF INTERIM RESULTS 2023 Regulatory Filings	2023-08-23	English
CHANGE OF ADDRESS OF PRINCIPAL OFFICE IN HONG KONG Regulatory Filings	2023-08-23	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2023 Regulatory Filings	2023-08-22	English
Next Day Disclosure Return Regulatory Filings	2023-08-15	English
DATE OF BOARD MEETING Regulatory Filings	2023-08-11	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023 Regulatory Filings	2023-08-02	English
Monthly Return of Equity Issuer on movements in Securities for the month ended 31 July 2023 Regulatory Filings	2023-08-01	English
VOLUNTARY ANNOUNCEMENT - SHANGHAI PUBLIC HEALTH CLINICAL CENTER PRESENTED CLINICAL RESULTS OF ASC22 (ENVAFOLIMAB) IN COMBINATION WITH CHIDAMIDE FOR FUNCTIONAL CURE OF HIV INFECTION AT THE 12TH IAS CON Regulatory Filings	2023-07-25	English
NOTICE OF BOARD MEETING Regulatory Filings	2023-07-21	English
VOLUNTARY ANNOUNCEMENT LETTER OF INTENT FOR COOPERATION IN INVESTMENT PROMOTION PROJECT Regulatory Filings	2023-07-21	English
Next Day Disclosure Return Regulatory Filings	2023-07-20	English
VOLUNTARY ANNOUNCEMENT - GANNEX ANNOUNCES THE COMPLETION OF PATIENT ENROLLMENT FOR PHASE II CLINICAL TRIAL OF ASC42, AN FXR AGONIST, FOR PRIMARY BILIARY CHOLANGITIS Regulatory Filings	2023-07-20	English
Next Day Disclosure Return Regulatory Filings	2023-07-19	English
POSITIVE PROFIT ALERT Regulatory Filings	2023-07-18	English
Next Day Disclosure Return Regulatory Filings	2023-07-14	English
Next Day Disclosure Return Regulatory Filings	2023-07-13	English
Next Day Disclosure Return Regulatory Filings	2023-07-12	English
Next Day Disclosure Return Regulatory Filings	2023-07-11	English
Next Day Disclosure Return Regulatory Filings	2023-07-10	English
Next Day Disclosure Return Regulatory Filings	2023-07-07	English
Next Day Disclosure Return Regulatory Filings	2023-07-06	English
Next Day Disclosure Return Regulatory Filings	2023-07-05	English
Next Day Disclosure Return Regulatory Filings	2023-07-04	English
Monthly Return of Equity Issuer on movements in Securities for the month ended 30 June 2023 Regulatory Filings	2023-07-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023 Regulatory Filings	2023-07-04	English
Next Day Disclosure Return Regulatory Filings	2023-07-03	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Regulatory Filings	2023-06-30	English
APPOINTMENT OF EXECUTIVE DIRECTORS, NON-EXECUTIVE DIRECTOR AND INDEPENDENT NON-EXECUTIVE DIRECTORS Regulatory Filings	2023-06-30	English
Next Day Disclosure Return Regulatory Filings	2023-06-30	English
VOLUNTARY ANNOUNCEMENT - PROPOSED SHARE REPURCHASE UNDER THE REPURCHASE MANDATE Regulatory Filings	2023-06-29	English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON JUNE 29, 2023 Regulatory Filings	2023-06-29	English
Next Day Disclosure Return Regulatory Filings	2023-06-28	English
Next Day Disclosure Return Regulatory Filings	2023-06-27	English
Next Day Disclosure Return Regulatory Filings	2023-06-26	English
VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES POSTER PRESENTATION OF PHASE II STUDY OF ASC42 FXR AGONIST FOR FUNCTIONAL CURE OF CHRONIC HEPATITIS B AT EASL CONGRESS 2023 Regulatory Filings	2023-06-26	English
Next Day Disclosure Return Regulatory Filings	2023-06-23	English
Next Day Disclosure Return Regulatory Filings	2023-06-21	English
Next Day Disclosure Return Regulatory Filings	2023-06-20	English
Next Day Disclosure Return Regulatory Filings	2023-06-19	English
Next Day Disclosure Return Regulatory Filings	2023-06-15	English
SUPPLEMENTAL ANNOUNCEMENT ON PROVISION FOR IMPAIRMENT OF ASSETS FOR 2022; BUSINESS UPDATES; AND CHANGE IN USE OF PROCEEDS Regulatory Filings	2023-06-14	English
Notification Letter to Non-Registered Holders of Shares with Request Form - Notice of Publication of Circular containing Notice of Annual General Meeting Regulatory Filings	2023-06-05	English
Form of Proxy for the 2023 Annual General Meeting Regulatory Filings	2023-06-05	English
Notice of 2023 Annual General Meeting Regulatory Filings	2023-06-05	English
Proposals for General Mandates to Issue Shares and to Repurchase Shares, Re-Election of Retiring Directors, Proposed Change of Auditor and Notice of Annual General Meeting Regulatory Filings	2023-06-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023 Regulatory Filings	2023-06-05	English
Monthly Return of Equity Issuer on movements in Securities for the month ended 31 May 2023 Regulatory Filings	2023-06-01	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 31 MAY 2023 Regulatory Filings	2023-05-31	English
PROPOSED CHANGE OF AUDITOR Regulatory Filings	2023-05-24	English
VOLUNTARY ANNOUNCEMENT - PROPOSED SHARE REPURCHASE UNDER THE REPURCHASE MANDATE Regulatory Filings	2023-05-22	English
Next Day Disclosure Return Regulatory Filings	2023-05-12	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2023 Regulatory Filings	2023-05-10	English
VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES CHINA NMPA APPROVAL OF CONDUCTING A PHASE IIA CLINICAL TRIAL FOR ASC10 TO TREAT RESPIRATORY SYNCYTIAL VIRUS INFECTION Regulatory Filings	2023-05-08	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2023 Regulatory Filings	2023-05-05	English
Monthly Return of Equity Issuer on movements in Securities for the month ended 30 April 2023 Regulatory Filings	2023-05-02	English
VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES ASC40, A FIRST-IN-CLASS, ONCE-DAILY ORAL FASN INHIBITOR, ACHIEVED ENDPOINTS IN PHASE II CLINICAL TRIAL FOR ACNE Regulatory Filings	2023-05-02	English
FORM OF PROXY FOR ANNUAL GENERAL MEETING (or any adjournment thereof) Regulatory Filings	2023-04-27	English
Annual Report 2022 Regulatory Filings	2023-04-27	English
(1)GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES, (2)RE-ELECTION OF RETIRING DIRECTORS, (3)PROPOSED APPOINTMENT OF EXECUTIVE DIRECTORS, NON-EXECUTIVE DIRECTOR AND INDEPENDENT NON-EXECUTIVE DIRECTORS Regulatory Filings	2023-04-27	English
NOTICE OF ANNUAL GENERAL MEETING Regulatory Filings	2023-04-27	English
NOMINATE APPOINTMENT OF EXECUTIVE DIRECTORS, NON-EXECUTIVE DIRECTOR AND INDEPENDENT NON-EXECUTIVE DIRECTORS Regulatory Filings	2023-04-26	English
Notification Letter to Non-Registered Holders of Shares with Request Form - Notice of Publication of Annual Report 2022 Regulatory Filings	2023-04-25	English
Annual Report 2022 Regulatory Filings	2023-04-25	English
Monthly Return of Equity Issuer on movements in Securities for the month ended 31 March 2023 Regulatory Filings	2023-04-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2023 Regulatory Filings	2023-04-03	English
RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2022 Regulatory Filings	2023-03-30	English
DATE OF BOARD MEETING Regulatory Filings	2023-03-20	English
VOLUNTARY ANNOUNCEMENT - VIRAL DISEASE BUSINESS UPDATE Regulatory Filings	2023-03-20	English
ANNUAL RESULTS OF ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2022 Regulatory Filings	2023-03-20	English
VOLUNTARY ANNOUNCEMENT - ASCLETIS STATES NO BANK ACCOUNT IN SILICON VALLEY BANK OR ITS AFFILIATES Regulatory Filings	2023-03-13	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2023 Regulatory Filings	2023-03-03	English
Monthly Return of Equity Issuer on movements in Securities for the month ended 28 February 2023 Regulatory Filings	2023-03-01	English
VOLUNTARY ANNOUNCEMENT - ASCLETIS PRESENTED POSITIVE PHASE I CLINICAL DATA FOR BROAD-SPECTRUM ANTIVIRAL DOUBLE PRODRUG ASC10 AT CROI 2023 Regulatory Filings	2023-02-21	English
NOTICE OF BOARD MEETING Regulatory Filings	2023-02-20	English
VOLUNTARY ANNOUNCEMENT - ORAL PRESENTATION AT APASL ANNUAL MEETING 2023 DEMONSTRATES ASC22, A SUBCUTANEOUS PD-L1 ANTIBODY, CAN ACHIEVE FUNCTIONAL CURE OF CHRONIC HEPATITIS B Regulatory Filings	2023-02-16	English
Monthly Return of Equity Issuer on movements in Securities for the month ended 31 January 2023 Regulatory Filings	2023-02-02	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2023 Regulatory Filings	2023-02-02	English
VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES U.S. FDA APPROVAL OF CONDUCTING A PHASE IIA CLINICAL TRIAL FOR ASC10 TO TREAT RESPIRATORY SYNCYTIAL VIRUS INFECTION Regulatory Filings	2023-01-31	English
VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES IND APPROVAL OF ASC10 FOR MONKEYPOX INDICATION BY CHINA NMPA Regulatory Filings	2023-01-26	English
VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES ENTERING INTO A SUPPLY AGREEMENT OF RITONAVIR TABLETS WITH SIMCERE Regulatory Filings	2023-01-17	English
VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES DOSING OF 4 HEALTHY SUBJECTS OF THE FIRST COHORT IN MULTIPLE-DOSE ESCALATION PHASE I CLINICAL TRIAL OF ORAL 3CLPRO INHIBITOR ASC11 FOR COVID-19 Regulatory Filings	2023-01-16	English
COMPLETION OF DISCLOSEABLE TRANSACTION DISPOSAL OF LAND USE RIGHTS AND BUILDINGS Regulatory Filings	2023-01-10	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022 Regulatory Filings	2023-01-05	English
Monthly Return of Equity Issuer on movements in Securities for the month ended 31 December 2022 Regulatory Filings	2023-01-03	English
ANNOUNCEMENT - LEGAL PROCEEDINGS INVOLVING THE GROUP Regulatory Filings	2023-01-02	English

Filings by year

2026 22 filings
2025 159 filings
2024 184 filings
2023 178 filings
2022 127 filings
2021 160 filings
2020 98 filings
2019 74 filings
2018 63 filings
2017 33 filings
2016 31 filings
2015 30 filings
2014 27 filings
2013 29 filings
2012 41 filings
2011 29 filings
2010 27 filings
2009 23 filings
2008 16 filings
2007 23 filings
2006 18 filings
2005 19 filings
2004 18 filings
2003 13 filings
2002 8 filings
2001 7 filings
2000 8 filings
1999 5 filings